Nephros NEPH
NASDAQ NEPH
$3.31 +0.24 (+7.82%)
At close: Nov 12, 2026 · 4:00 PM EST

Nephros (NEPH) Non-Current Deferred Tax Liability (2023 - 2025)

Updated

Analysis

Nephros (NEPH) Non-Current Deferred Tax Liability (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn
3 Danaher 163.29 Bn 142.96 Bn 3.84 Bn
4 Intuitive Surgical 152.47 Bn 132.89 Bn 2.08 Bn
5 Medtronic 131.95 Bn 97.47 Bn 6.34 Bn
6 Stryker 119.59 Bn 105.78 Bn 4.25 Bn
7 Boston Scientific 64.18 Bn 59.61 Bn 3.43 Bn
8 Edwards Lifesciences 60.93 Bn 44.24 Bn 1.35 Bn
9 Medline 52.61 Bn 49.74 Bn 1.93 Bn
10 Nephros 35.98 Mn 17.32 Mn 3.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -403,000.00
Dec 31, 2024 -473,000.00
Dec 31, 2023 -558,000.00
API Access

Nephros Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=NEPH&period=max&api_key=YOUR_API_KEY